Hippo includes a full set of CQC (Care Quality Commission) monitoring indicators designed to help practices meet clinical safety and medicines management requirements.
These indicators track whether key safety checks (like blood tests, kidney function, weight, and reviews) have been completed for patients on high-risk or regularly monitored medicines.
You can use them in Recall Campaigns to automate patient invitations or view them in Indicator Performance to track compliance.
π Medication Monitoring Indicators
CQCDOAC000βCQCDOAC007 β DOAC Monitoring
These indicators help ensure safe prescribing for patients on DOACs by checking their weight, renal function, and blood test results.
Indicator | Description | What It Checks |
CQCDOAC000 | Weight β patients on DOAC | Confirms a recent weight is recorded for dosing accuracy. |
CQCDOAC001 / 001A / 001B | Creatinine / Creatinine clearance | Checks for recent serum creatinine and calculated CrCl (requires up-to-date weight). |
CQCDOAC002 / 002A / 002B | Annual creatinine / CrCl | Ensures annual renal function monitoring for all DOAC patients. |
CQCDOAC003 / 003A / 003B | 3-month CrCl β CKD4/5 | Ensures quarterly CrCl checks for advanced kidney disease. |
CQCDOAC004 / 004A / 004B | 6-month CrCl β CKD3 | Ensures 6-monthly CrCl checks for moderate kidney disease. |
CQCDOAC005 | Annual haemoglobin | Confirms Hb checked within the past year. |
CQCDOAC006 | Review β low haemoglobin | Identifies DOAC patients with low Hb who have been reviewed. |
CQCDOAC007 | Appropriate kidney function | Checks that renal function remains within safe range for DOAC use. |
β οΈ Patients wonβt appear in the B-version indicators until both a recent creatinine and weight are recorded.
CQCWARFARIN001β002 β Warfarin Monitoring
Indicator | Description | What It Checks |
CQCWARFARIN001 | INR monitoring | Ensures patients on warfarin have appropriately monitored INR. |
CQCWARFARIN002 | Review β high INR | Confirms that patients with high INR have been reviewed. |
CQCMETFORMIN001β002 β Metformin Monitoring
Indicator | Description | What It Checks |
CQCMETFORMIN001 | Kidney function β metformin | Confirms recent renal function test for metformin safety. |
CQCMETFORMIN002 | Review β low kidney function | Checks that metformin patients with low kidney function have been reviewed. |
CQCAMIODERONE001 β Amiodarone Monitoring
Indicator | Description | What It Checks |
CQCAMIODERONE001 | Function checks β amiodarone | Confirms that kidney, liver, and thyroid function tests are up to date. |
CQCLI001β002 β Lithium Monitoring
Indicator | Description | What It Checks |
CQCLI001 | Serum lithium level | Confirms that lithium level has been checked within the required timeframe. |
CQCLI002 | Ca, kidney, and thyroid monitoring | Checks that calcium, renal, and thyroid function tests are current. |
π DMARDs Indicators
CQCMET001 / CQCLEF001 / CQCAZA001 β DMARD Monitoring
Indicator | Description | What It Checks |
CQCMET001 | Methotrexate monitoring | Confirms recent FBC, renal, and liver function tests for methotrexate. |
CQCLEF001 | Leflunomide monitoring | Ensures up-to-date FBC, renal, liver, BP, and weight. |
CQCAZA001 | Azathioprine monitoring | Checks that FBC, renal, and liver function tests are complete. |
CQCACEARB001 / CQCALDANT001 β Heart & Kidney Function Monitoring
Indicator | Description | What It Checks |
CQCACEARB001 | Kidney function β ACEi/ARB | Ensures patients on ACE inhibitors or ARBs have up-to-date renal function. |
CQCALDANT001 | Kidney function β heart failure (aldosterone antagonists) | Checks renal monitoring for heart failure patients on aldosterone antagonists. |
π‘ Why These Indicators Matter
CQC indicators help practices:
Stay compliant with medicines safety and CQC standards
Identify patients overdue for essential blood monitoring
Ensure safe prescribing for high-risk or renal-dependent drugs
Provide clear audit evidence for regulators and PCNs
π§ Where to Find Them in Hippo
You can find CQC indicators in:
Recall Campaign setup β under the βCQCβ framework
Indicator Performance dashboard β to monitor completion and progress
